His primary scientific interests are in Antigen, Immunology, Human leukocyte antigen, Monoclonal antibody and Melanoma. Soldano Ferrone has included themes like Molecular biology, Antibody, Cell culture and Pathology in his Antigen study. His Immunology study incorporates themes from Cancer and Cancer research.
His work carried out in the field of Human leukocyte antigen brings together such families of science as Immunohistochemistry, Antigen processing and CTL*, Cytotoxic T cell, CD8. His Monoclonal antibody research is multidisciplinary, relying on both Malignant transformation and Serology. He works mostly in the field of Melanoma, limiting it down to concerns involving Tumor progression and, occasionally, Signal transduction.
Soldano Ferrone mainly investigates Antigen, Immunology, Monoclonal antibody, Molecular biology and Human leukocyte antigen. His Antigen research includes elements of Cytotoxic T cell, Antibody, Melanoma and Cell culture. Immune system, Immunotherapy, T cell, Lymphocyte and Histocompatibility are the subjects of his Immunology studies.
The concepts of his Monoclonal antibody study are interwoven with issues in Virology and Pathology. The various areas that Soldano Ferrone examines in his Molecular biology study include In vitro, Cytotoxicity, Antiserum, Pan-T antigens and Serology. His Human leukocyte antigen research incorporates themes from Beta-2 microglobulin, Antigen processing, Antigen presentation, CD8 and Major histocompatibility complex.
Soldano Ferrone spends much of his time researching Cancer research, Immunotherapy, Immunology, Melanoma and Immune system. His work deals with themes such as Cancer cell, Cancer, Antigen, CSPG4 and Chimeric antigen receptor, which intersect with Cancer research. Much of his study explores Antigen relationship to Antibody.
Soldano Ferrone usually deals with Immunotherapy and limits it to topics linked to Monoclonal antibody and Epitope. His research brings together the fields of Cytotoxic T cell and Immunology. In his study, which falls under the umbrella issue of Human leukocyte antigen, Pathology is strongly linked to CD8.
Soldano Ferrone focuses on Cancer research, Immunology, Immunotherapy, Melanoma and Cancer. Human leukocyte antigen, Immune system, Antigen, Tumor microenvironment and Cetuximab are among the areas of Immunology where Soldano Ferrone concentrates his study. The concepts of his Human leukocyte antigen study are interwoven with issues in Antigen processing, Antigen presentation, Immunogenicity, Molecular biology and Major histocompatibility complex.
While the research belongs to areas of Antigen, Soldano Ferrone spends his time largely on the problem of Tumor antigen, intersecting his research to questions surrounding Cytokine secretion. His studies deal with areas such as T cell, Cell culture, Cancer stem cell and Immunosurveillance as well as Immunotherapy. His studies in Cancer integrate themes in fields like Ex vivo, Antibody and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
Francesco M. Marincola;Elizabeth M. Jaffee;Daniel J. Hicklin;Soldano Ferrone.
Advances in Immunology (2000)
Major Histocompatibility Complex Class I-related Chain A and UL16-Binding Protein Expression on Tumor Cell Lines of Different Histotypes Analysis of Tumor Susceptibility to NKG2D-dependent Natural Killer Cell Cytotoxicity
Daniela Pende;Paola Rivera;Stefania Marcenaro;Chien Chung Chang.
Cancer Research (2002)
Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.
Soldano Ferrone;Francesco M. Marincola.
Immunology Today (1995)
Antigen-processing machinery breakdown and tumor growth.
Barbara Seliger;Markus J Maeurer;Soldano Ferrone.
Immunology Today (2000)
Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide.
M.A. Pellegrino;S. Ferrone;M.P. Dierich;R.A. Reisfeld.
Clinical Immunology and Immunopathology (1975)
Immunotherapy of Cancer in 2012
John M. Kirkwood;Lisa H. Butterfield;Ahmad A. Tarhini;Hassane Zarour.
CA: A Cancer Journal for Clinicians (2012)
HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
Daniel J Hicklin;Francesco M Marincola;Soldano Ferrone.
Molecular Medicine Today (1999)
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
Marta Santisteban;Jennifer M. Reiman;Michael K. Asiedu;Marshall D. Behrens.
Cancer Research (2009)
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
Michael Campoli;Soldano Ferrone.
Oncogene (2008)
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
C. M. D'urso;Zhigang Wang;Yan Cao;R. Tatake.
Journal of Clinical Investigation (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Scripps Research Institute
Harvard University
University of Pittsburgh
Vanderbilt University
University of Genoa
University of Pittsburgh
University of North Carolina at Chapel Hill
National Institutes of Health
Chinese Academy of Sciences
University of Pittsburgh
École Polytechnique Fédérale de Lausanne
University of Colorado Colorado Springs
City University of Hong Kong
University of Florida
Rutgers, The State University of New Jersey
University of Natural Resources and Life Sciences
Virginia Tech
International Rice Research Institute
Ghent University
Monash University
Yale School of Medicine
Indian Institute of Technology Kharagpur
University of Palermo
Johns Hopkins University School of Medicine
Uppsala University
University of Edinburgh